Home

The VenusP-Valve (Venus Medtech) transcatheter pulmonic valve replacement (TPVR) system has been approved by China’s National Medical Products Administration (NMPA) for the treatment of severe pulmonary regurgitation in patients who have undergone a congenital heart defect (CHD) procedure with native right ventricular outflow tract (RVOT).

For the registration application, the NMPA has accepted trial data submitted to support the device’s CE mark approval, which was received in April 2022. The device was approved by the US Food and Drug Administration (FDA) for compassionate use in two cases in the USA in May 2022 and the first compassionate case was completed successfully in June 2022.

Following its first clinical implantation in 2013, VenusP-Valve has been used in nearly 300 cases for humanitarian reasons, spanning more than 20 countries and regions in Asia, Europe, North America, and South America, Venus Medtech said in a press release.

According to three-year follow-up data of the European clinical trial, the success rate for TPVR with VenusP-Valve is 100% in 64 patients (some patients have not been included due to the ongoing pandemic), the company adds. All-cause mortality and surgical reintervention rates were zero. In addition, no moderate or severe pulmonary regurgitation was observed. Paravalvular leakage and tricuspid regurgitation were mild or below in 96.87% of subjects. Meanwhile, five-year follow-up data of the Chinese trial reported a 3.64% postoperative five-year all-cause mortality rate.

Commenting on the approval, Ge Junbo (Zhongshan Hospital, Shanghai, China), principal Investigator of the Chinese clinical trial of VenusP-Valve, said: “The first clinical application of VenusP-Valve dated to May 2013, and we were all impressed by its excellent immediate outcomes. The overall clinical results of the multicentre study testified to effective and steady improvements it brought to patients’ cardiac function, making me extremely proud of this Chinese-developed valve product. Moreover, its recent launch in Europe and compassionate use in the USA demonstrated the recognition it received from the international medical community. That is how a truly meaningful innovative medical device is defined.”

Source CardiovascularNews

Duc Tin CLinic

Chia sẽ qua facebook bài: VenusP-Valve gains approval from China’s NMPA

Chia sẽ qua google bài: VenusP-Valve gains approval from China’s NMPA

Chia sẽ qua twitter bài: VenusP-Valve gains approval from China’s NMPA

Chia sẽ qua MySpace bài: VenusP-Valve gains approval from China’s NMPA

Chia sẽ qua LinkedIn bài: VenusP-Valve gains approval from China’s NMPA

Chia sẽ qua stumbleupon bài: VenusP-Valve gains approval from China’s NMPA

Chia sẽ qua icio bài: VenusP-Valve gains approval from China’s NMPA

Chia sẽ qua digg bài: VenusP-Valve gains approval from China’s NMPA

Chia sẽ qua yahoo bài: VenusP-Valve gains approval from China’s NMPA

Tin tức liên quan

Enrolment reaches midway point in trial of Early Bird bleed monitoring system

Eight-fold increased risk of heart attack seen in patients with subclinical obstructive coronary atherosclerosis

ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

Blood pressure successfully cut in RADIANCE II ultrasound renal denervation trial

New data examine mortality rates and cardiac damage in early-stage aortic stenosis patients

SUPPORT CONSULTANT

Make an Appointment

I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

I sincerely thank you !. Tel: 0938303275

Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.